CRISPR THERAPEUTICS AG
Assets & Liabilities
| Fiscal Year | Total Liabilities | Total Assets | Cash on Hand |
|---|---|---|---|
| FY2017 | $83.5M | $271.3M | $239.8M |
| FY2018 | $96.8M | $489.0M | $456.6M |
| FY2019 | $127.3M | $1.07B | $943.8M |
| FY2020 | $163.7M | $1.83B | $1.17B |
| FY2021 | $352.4M | $2.75B | $923.0M |
Assets & Liabilities
| Fiscal Year | Total Liabilities | Total Assets | Cash on Hand |
|---|---|---|---|
| FY2017 | $83.5M | $271.3M | $239.8M |
| FY2018 | $96.8M | $489.0M | $456.6M |
| FY2019 | $127.3M | $1.07B | $943.8M |
| FY2020 | $163.7M | $1.83B | $1.17B |
| FY2021 | $352.4M | $2.75B | $923.0M |